Regulus Therapeutics Inc. (NASDAQ: RGLS) Stock Information | RedChip

Regulus Therapeutics Inc. (NASDAQ: RGLS) Listen to this Section


$1.60
+0.0100 ( +0.63% ) 139.7K

Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.

Market Data


Open


$1.60

Previous close


$1.59

Volume


139.7K

Market cap


$105.40M

Day range


$1.56 - $1.64

52 week range


$1.08 - $3.79

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Aug 14, 2023
4 Insider transactions 1 Aug 14, 2023
4 Insider transactions 1 Aug 14, 2023
4 Insider transactions 1 Aug 14, 2023
10-q Quarterly Reports 53 Aug 08, 2023
8-k 8K-related 14 Aug 08, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.